FDA Inspection
ARK-LA-TEX Fertility and Reproductive Medicine, PMCARK-LA-TEX Fertility and Reproductive Medicine, PMC – FDA Inspection, Aug 29, 2025
Record Details
This FDA Inspection record concerns ARK-LA-TEX Fertility and Reproductive Medicine, PMC, with an inspection on August 29, 2025, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- August 29, 2025
- Product Type
- Biologics
View Company Profile
ID · f0b22434-9aac-4e96-b4fe-5bc43ed11ffa
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1280425
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of ARK-LA-TEX Fertility and Reproductive Medicine, PMC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 23, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 30, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 29, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 26, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for ARK-LA-TEX Fertility and Reproductive Medicine, PMC
- FDA Inspection 1217533 - 2023-08-23
- FDA Inspection 1042561 - 2017-11-30
- FDA Inspection 929590 - 2015-05-29
- FDA Inspection 831050 - 2013-04-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.